172 related articles for article (PubMed ID: 24257751)
1. Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.
Rather MI; Swamy S; Gopinath KS; Kumar A
J Biol Chem; 2014 Jan; 289(2):968-76. PubMed ID: 24257751
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics.
Rather MI; Nagashri MN; Swamy SS; Gopinath KS; Kumar A
J Biol Chem; 2013 Jan; 288(1):608-18. PubMed ID: 23166327
[TBL] [Abstract][Full Text] [Related]
3. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
5. Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.
Mikami T; Hada T; Chosa N; Ishisaki A; Mizuki H; Takeda Y
J Oral Pathol Med; 2013 Feb; 42(2):133-9. PubMed ID: 22672247
[TBL] [Abstract][Full Text] [Related]
6. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
Yue ZW; Liu JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
[No Abstract] [Full Text] [Related]
7. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
[TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
9. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
[TBL] [Abstract][Full Text] [Related]
10. WT1 promotes invasion of NSCLC via suppression of CDH1.
Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
[TBL] [Abstract][Full Text] [Related]
11. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418
[TBL] [Abstract][Full Text] [Related]
12. The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53.
Stanhope-Baker P; Kessler PM; Li W; Agarwal ML; Williams BR
J Biol Chem; 2004 Aug; 279(32):33575-85. PubMed ID: 15155752
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target.
Shahidul Makki M; Cristy Ruteshouser E; Huff V
Exp Cell Res; 2013 Mar; 319(5):612-22. PubMed ID: 23291318
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization.
Masi G; Iacobone M; Sinigaglia A; Mantelli B; Pennelli G; Castagliuolo I; Palù G; Barzon L
PLoS One; 2014; 9(5):e97994. PubMed ID: 24842573
[TBL] [Abstract][Full Text] [Related]
15. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
16. WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene.
Montano G; Vidovic K; Palladino C; Cesaro E; Sodaro G; Quintarelli C; De Angelis B; Errichiello S; Pane F; Izzo P; Grosso M; Gullberg U; Costanzo P
Oncotarget; 2015 Sep; 6(29):28223-37. PubMed ID: 26320177
[TBL] [Abstract][Full Text] [Related]
17. Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.
Busch M; Schwindt H; Brandt A; Beier M; Görldt N; Romaniuk P; Toska E; Roberts S; Royer HD; Royer-Pokora B
Hum Mol Genet; 2014 Aug; 23(15):3958-74. PubMed ID: 24619359
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
[TBL] [Abstract][Full Text] [Related]
20. WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1.
Lv L; Chen G; Zhou J; Li J; Gong J
J Exp Clin Cancer Res; 2015 Oct; 34():119. PubMed ID: 26462627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]